Tovorafenib companion diagnostic - Foundation Medicine
Alternative Names: Tovorafenib FoundationOne® CDx - Foundation MedicineLatest Information Update: 30 Sep 2022
At a glance
- Originator Foundation Medicine
- Developer Day One Biopharmaceuticals; Foundation Medicine
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Glioma